Search Results - Mahsoem Ali
- Showing 1 - 2 results of 2
-
1
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study by Lenka N. C. Boyd, Lenka N. C. Boyd, Lenka N. C. Boyd, Lynn E. Nooijen, Lynn E. Nooijen, Lynn E. Nooijen, Mahsoem Ali, Mahsoem Ali, Mahsoem Ali, Jisce R. Puik, Jisce R. Puik, Jisce R. Puik, Jasmine Moustaquim, Stephanie M. Fraga Rodrigues, Stephanie M. Fraga Rodrigues, Stephanie M. Fraga Rodrigues, Robert Broos, Robert Broos, Robert Broos, Ali Belkouz, Laura L. Meijer, Tessa Y. S. Le Large, Tessa Y. S. Le Large, Tessa Y. S. Le Large, Joris I. Erdmann, Gerrit K. J. Hooijer, Michal Heger, Michal Heger, Michal Heger, Hanneke W. M. Van Laarhoven, Hanneke W. M. Van Laarhoven, Eva Roos, Geert Kazemier, Geert Kazemier, Elisa Giovannetti, Elisa Giovannetti, Elisa Giovannetti, Joanne Verheij, Heinz-Josef Klümpen
Published in Frontiers in Pharmacology (2023-10-01)Get full text
Article -
2
Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer by Lenka N.C. Boyd, Mahsoem Ali, Jisce R. Puik, Annalisa Comandatore, Laura Ginocchi, Laura L. Meijer, Rutger-Jan Swijnenburg, Roberta Tartarini, Tessa Y.S. Le Large, Luca Morelli, Ingrid Garajova, Marc G. Besselink, Andrea Mambrini, Johanna W. Wilmink, Adam E. Frampton, Hanneke W.M. van Laarhoven, Elisa Giovannetti, Geert Kazemier
Published in The Journal of Liquid Biopsy (2024-09-01)Get full text
Article
